Cargando…
Exploring NFκB pathway as a potent strategy to mitigate COVID-19 severe morbidity and mortality
The pandemic of coronavirus disease 2019 (COVID-19), for which there does not appear to be an approved cure, the primary treatment options consist of non-pharmacological preventive measures and supportive treatment that are aimed at halting the progression of the disease. Nuclear factor kappa B (NFk...
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
PAGEPress Publications, Pavia, Italy
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9614690/ https://www.ncbi.nlm.nih.gov/pubmed/36313924 http://dx.doi.org/10.4081/jphia.2022.1679 |